Newark Beth Israel Medical Center   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Newark NJ United States (1900)

Organization Overview

First Clinical Trial
2004
NCT00299221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Barnabas Health, Newark Beth Israel Medical Center | Children's Hospital of NJ at Newark Beth Israel Medical Center | Newark Beth Israel | Newark Beth Israel Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Acute Pain (Phase 2)

Anemia, Sickle Cell (Phase 4)

Emergencies (Phase 2)

Facial Neuralgia (Phase 3)

Heart Failure (Phase 4)

Migraine Disorders (Phase 3)

Neuralgia (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 10